• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA Clears Box DICOM Viewer as Class II Medical Device

Article

The FDA has cleared Box DICOM Viewer, part of the Box for Healthcare solution.

Box has received FDA clearance for its DICOM Viewer, the company announced at HIMSS 2016.

Box, an enterprise content management platform, developed a solution tailored for hospitals that streamlines referral management, enables medical professionals to share and view DICOM files, and provides access to critical data that is often “trapped in proprietary hospital-based enterprise systems,” a release said.

The Box DICOM viewer is part of the Box for Healthcare solution, which includes a content management platform that allows hospitals to securely share and manage content in the cloud from any device in real time; Box Governance, which enables customers to comply with regulatory policies, satisfy e-discovery requests, and manage sensitive information; Box Consulting Services, which provides expertise to help customers transform their clinical workflows with custom integration; and Partner Integration Capabilities, which supports HIPAA-compliant faxing services and communication with hospital based record systems, the company said.

The Box DICOM Viewer is now generally available and has been FDA cleared as a Class II Medical Device, and can therefore be used for diagnostic purposes.[[{"type":"media","view_mode":"media_crop","fid":"46782","attributes":{"alt":"Box DICOM Viewer","class":"media-image","id":"media_crop_3507474655434","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5454","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"Image courtesy of Box.","typeof":"foaf:Image"}}]]

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.